Clin2
NCT07230730Possibly a fitRecruiting

Testing a new drug for high cholesterol

Hyperlipidemia

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests a new medication called SHR-1918 for people with high cholesterol who are already on statins. The goal is to see if it can further lower cholesterol and improve health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
900 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You must be on a steady statin dose and still have high LDL cholesterol despite treatment.
  • You must have high triglycerides as well.
  • You cannot have poorly controlled high blood pressure.
  • You cannot have certain severe kidney or liver problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07229937Recruiting· Phase 2
Testing an experimental drug for high cholesterol

This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.

Harbin, Heilongjiang
NCT07404553Recruiting· Phase 2/Phase 3
Study of SHR-1918 for high cholesterol not controlled by statins and PCSK9 inhibitors

This trial tests a new medicine, SHR-1918, for people whose bad cholesterol (LDL-C) stays high even when they take statins and another type of cholesterol-lowering drug called a PCSK9 inhibitor. It aims to see if this additional treatment can lower their cholesterol more effectively.

Nanjing, Jiangsu
NCT07349615Recruiting· Phase 3
Study of SHR-1918 for high triglycerides

This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.

Shanghai, Shanghai Municipality
NCT07695597Recruiting· Phase 2
Study of SYH2070 for people with high cholesterol and triglycerides

This trial tests an investigational injection called SYH2070 to lower cholesterol and triglycerides in people who are already on a stable statin therapy. It may be a new option for those with mixed hyperlipidemia who need additional lipid control.

Hangzhou, Zhejiang
NCT07441317Not yet recruiting· Phase 3
Testing a new drug for stubborn high cholesterol

This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.

NCT07777003Not yet recruiting· Phase 1
Study of a new drug for mild high cholesterol

This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.

Hear when a new Hyperlipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.